AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 6.45 |
Market Cap | 341.27M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -2.09 |
PE Ratio (ttm) | -3.28 |
Forward PE | n/a |
Analyst | Hold |
Ask | 7.07 |
Volume | 403,995 |
Avg. Volume (20D) | 833,819 |
Open | 6.87 |
Previous Close | 6.83 |
Day's Range | 6.54 - 6.92 |
52-Week Range | 5.95 - 19.30 |
Beta | undefined |
About NUS
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shapi...
Analyst Forecast
According to 2 analyst ratings, the average rating for NUS stock is "Hold." The 12-month stock price forecast is $6.88, which is an increase of 0.22% from the latest price.
Next Earnings Release
Analysts project revenue of $456.62M, reflecting a -6.55% YoY shrinking and earnings per share of 0.28, making a -24.32% decrease YoY.
1 week ago · https://thefly.com
Nu Skin generated about five-times return on Mavely investment, says JefferiesAfter Nu Skin announced the sale of its marketing tech platform business, Mavely, to Summit Partners portfolio company Later, Jefferies noted that this transaction generated about a five-times return ...
2 months ago · seekingalpha.com
Nu Skin: New Products And Ongoing Digital Transformation Imply UndervaluationNu Skin Enterprises, Inc. demonstrates a tested business model with long-term free cash flow generation, supported by acquisitions, new products, and digital transformation. Despite recent earnings di...
2 months ago · seekingalpha.com
Nu Skin Enterprises, Inc. (NUS) Q3 2024 Earnings Call TranscriptNu Skin Enterprises, Inc. (NYSE:NUS ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Scott Pond - Vice President-Investor Relations Ryan Napierski - President and Ch...